C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 453/02 (2006.01) A61K 31/439 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2701126
The present invention relates to compounds and formulations capable of affecting nicotinic acetylcholine receptors (nAChRs), for example, as modulators of specific nicotinic receptor subtypes (specifically, the alpha7 nAChR subtype). The present invention also relates to methods for treating a wide variety of conditions and disorders, particularly those associated with dysfunction of the central and autonomic nervous systems.
L'invention concerne des composés et des formulations aptes à affecter des récepteurs nicotiniques d'acétylcholine (nAChRs), par exemple en tant que modulateurs de sous-types spécifiques de récepteur nicotinique (spécifiquement, le sous-type de nAChR alpha7). La présente invention concerne également des procédés de traitement d'une large variété d'états et de troubles, en particulier ceux associés au dysfonctionnement des systèmes nerveux centraux et autonomes.
Pfister Jurg R.
Venkatraman Meenakshi S.
Zhang Xiaoming
Comentis Inc.
Goudreau Gage Dubuc
LandOfFree
Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2083099